Flexion Therapeutics focuses on the development of innovative non-opioid therapies for the treatment of patients with osteoarthritis.

Flexion Therapeutics

Domain Not Resolving

HSTS

DNSSEC

IPv6

Apple Whitelist

Linode

Akamai Hosted

Comcast

SMTP2GO

Greenhouse

Associate Director, Corporate Development

Colby Cook

Director, Market Access/Strategic Accounts

Gigi Gallay

Director IT Development and Computerized Systems Validation

Jeff Barbour

Senior Director, National Field Access and Reimbursement

Kathy Burke

Senior Sales Director - Western United States

Kim Boeckenstedt

Medical Director • Oncology Research • Cancer Health Disparities • Early Detection

Lindsey C.

Regional Sales Director, Ohio Valley Region

Mark Cicacci

Associate Director Commercial Finance

Michael O'Neil

Musculoskeletal Business Manager-Region Field Sales Trainer

Adrian Garcia

Sr. Clinical Trial Manager

Amy Gauger

Alan W. Millinazzo

Elaine Jones

Samuel Colella

Andrew Schwab

Rafaele Tordjman

Heath Lukatch

Mark Stejbach

Bradley Bolzon

David A. Arkowitz

Chief Financial Officer

Christina Willwerth

Chief Strategy Officer

Art Fratamico

Chief Business Officer

Mike Clayman

Chief Executive Officer & Co-Founder

Scott Sigman

Consultant

Sr. Vice President, Program Management

Patrick Mahaffy

Chairman of the Board & Board of Director

Closed Health Care Companies (Top 10K)

Massachusetts Companies that Exited

Columbia University Alumni Founded Companies

Closed Northeastern US Companies (Top 10K)

Flexion Therapeutics advances drug candidates through clinical proof of concept and beyond, in partnership with pharmaceutical and biotechnology companies. By providing expertise and sharing risk, Flexion effectively expands the portfolios of its partners.

Post-IPO Debt - Flexion Therapeutics

Novo Ventures

Series B - Flexion Therapeutics

Pfizer Venture Investments

Series A - Flexion Therapeutics

Versant Ventures

Computer and Software Services and Scientific Services

Woburn

Massachusetts

United States

North America

Post-acquisition, Flexion Therapeutics says it will lay off 153 workers

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Flexion Therapeutics, Inc. - FLXN

Flexion Therapeutics shares soar 39% premarket on news to be acquired by Pacira Biosciences

5 Top Stock Gainers for Monday: Aspen, SoFi, Flexion Therapeutics

Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Is Flexion Therapeutics (FLXN) a Smart Long-term Buy?

Flexion Therapeutics Announces Pricing of Public Offering of Common Stock

India

Asia

Philippines

Ghana

Africa

HTML5

Lightbox

F5 NGINX

Wordpress

Gravity Forms

Google Drive

Google Fonts

DigiCert

GlobalSign

Google Compute Engine

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201, a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, an administered NaV1.7 inhibitor for the management of post-operative pain. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.

Flexion Therapeutics, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 29, 2024 2:39 PM	86ec23cf
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 29, 2024 2:39 PM	aaad7ddb
crunchbase trigger	general	Nov 22, 2024 7:44 AM	63fce039
crunchbase profile	general	Nov 23, 2024 1:52 AM	05180d76
li profile	general
translate crunchbase fundingrounds	general	Nov 23, 2024 2:30 AM	a8e2c9ef
peers	general	Sep 29, 2024 2:39 PM	7035f4e8
news basic	general	Sep 29, 2024 2:39 PM	67210346
bundesanzeiger	filings
financials download nd	financials
private financials	financials

FLXN

COM:FLEXIONTHERAPEUTICS

Flexion Therapeutics

Last Close

9.12

01/01 00:00